Oregon Health and Science University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Oregon Health and Science University sits in the top decile of US sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count).
Oregon Health and Science University: 546 sponsored US clinical trials, 91 recruiting.
Oregon Health and Science University sponsors 546 registered US clinical trials on ClinicalTrials.gov, 91 of them currently recruiting, and 370 completed. 73 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Oregon Health and Science University ranks in the top decile of sponsors by registered trial count (#67 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
370 of 420 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
546 total, page 4 of 11
Efficacy of a Multimodal Brain Health Intervention for Older African Americans
NCT04863378
carDIo-ttranSSfOrm nucLEar Imaging Study
NCT05259072
Two Way Crossover Closed Loop Study R-AP vs MPC
NCT05083559
Assessing Patient-provider Interactions During the Preoperative Anesthesia Consult
NCT04508543
Surgical Treatment of Children With OSA and Small Tonsils or Down Syndrome
NCT05154214
Digital Intervention Postoperative Protocol
NCT04828109
Preventing Perinatal Depression
NCT06525922
REmote Assessment and Dynamic Response Intervention II
NCT04686838
Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA
NCT04627662
Aerobic Exercise for Remyelination in Multiple Sclerosis
NCT04539002
REmote Assessment and Dynamic Response Intervention
NCT04542109
Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology
NCT04335110
Sugammadex To IMprove Bowel Function
NCT04546672
Two Way Crossover Closed Loop Study MPC vs FMPD
NCT04771403
Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus
NCT04605497
Utilization of Different Virtual Reality Experiences
NCT04828980
Support Via Technology: Living and Learning With Advancing FTD
NCT05338710
Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
NCT04387773
Pacific Northwest Female Urinary Incontinence Treatment Digital Awareness Project
NCT04464928
Yoga-Pilates Exercise & the Effects on Urethral Rhabdosphincter Morphology and Stress Urinary Incontinence
NCT04298671
Pancreatic Endotherapy for Refractory Chronic Pancreatitis
NCT04232670
Engaging Older Adults in Fall Prevention Using Motivational Interviewing (MI)
NCT04612842
Autism Access Link for Early Referral and Treatment
NCT04861740
The Peer-Based Retention of People Who Use Drugs in Rural Research
NCT03885024
Digital Capillary Refill for Monitoring of Sepsis
NCT04529655
Context Aware Data Gathering Study
NCT04154904
Assessment of a Decision Support Tool in Participants With Type 1 Diabetes
NCT04428645
Virtual Reality for Postoperative Pain Management
NCT04464304
TeleHepC Treatment Trial
NCT04798521
Cardiovascular Risk Stratification in Covid-19
NCT04555187
Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
NCT04205929
Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
NCT04396730
INTEGRATE-D: A Pilot Test to Support Integration of Medical and Psychosocial Care for People With Type II Diabetes
NCT04461405
Total Worker Health for Wildland Firefighters
NCT05753358
A Randomized Controlled Trial of a Multicomponent Walking Aid Program for People With MS
NCT04145934
Integrating WIC With Early Childhood Systems of Developmental Care
NCT04159038
CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
NCT04182763
Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
NCT03937908
Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI)
NCT04036773
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
NCT03975153
Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery
NCT03760718
Effects of Genotype on Resting State Connectivity During Methamphetamine Administration
NCT03973489
Influence of Yogic Breathwork on CSF Circulation
NCT03858309
Pharmacokinetics of Centella Asiatica in the Elderly
NCT03929250
Reducing Overdose After Release From Incarceration
NCT03902821
Neurofeedback in Alzheimer's Disease
NCT03790774
Delivering Early Intervention to Children With Down Syndrome
NCT03935620
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
NCT03793439
Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy
NCT03809572
Roo Study on Mom and Baby Well-Being
NCT03809598
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 52 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Oregon Health and Science University pipeline
91 recruiting of 546 indexed (17% open); 370 completed (68%).
Phase mix: 73 late (III/IV) vs 92 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Oregon Health and Science University: open-pipeline peers nationwide
Peers matched on 546 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Oregon Health and Science University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 546 trials (± recruiting share)
- Ohio State University · 552 trials · 21% recruiting
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Oregon Health and Science University page
546 registered trials is a research-attention snapshot, not an endorsement of Oregon Health and Science University or any single study.
- 91 of Oregon Health and Science University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Oregon Health and Science University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Oregon Health and Science University pipeline card: 546 registered trials from official public datasets.Report a data error.